Abstract:
La presente invención se refiere a un producto alimenticio completo de uso nutricional específico especialmente destinado para la nutrición por vía enteral u oral en caso de pacientes que presentan alteraciones neurológicas o neurodegenerativas, así como para la prevención de estados de deterioro cognitivo o del comportamiento, especialmente en ancianos, comprendiendo el producto alimenticio un ingrediente funcional especialmente diseñado para la nutrición de pacientes que padecen o son susceptibles de padecer alteraciones neurológicas o neurodegenerativas, deterioro cognitivo o trastornos del comportamiento, una mezcla de hidratos de carbono, una mezcla proteica, una mezcla lipídica, así como fibra alimentaria, inulina, vitaminas y minerales.
Abstract:
La presente invención se refiere a un suplemento alimenticio funcional destinado para suplementar la nutrición por vía enteral u oral en caso de pacientes que presentan alteraciones neurológicas o neurodegenerativas, así como para la prevención de estados de deterioro cognitivo o del comportamiento, especialmente en ancianos, comprendiendo el ingrediente funcional especialmente diseñado para la nutrición de pacientes que padecen o son susceptibles de padecer alteraciones neurológicas o neurodegenerativas, deterioro cognitivo o trastornos del comportamiento una mezcla de UMP (uridin monofosfato o uridina) y/o IMP (inosin monofosfato o inosina), vitaminas del grupo B (B1, B6, B9 y B7), fosfolípidos y gangliósidos,ácido siálico, así como una alta proporción de DHA.
Abstract:
The invention provides methods and compositions for improving fetal and child health and development through nutritional supplementation with, for example, sialic acid. Sialic acid can be provided to a female before, during and/or after pregnancy to improve the health and development of a fetus and/or child. The sialic acid can be in a variety of forms in the supplements.
Abstract:
The present invention relates to the field of nutraceuticals, and in particular to nutraceuticals comprising sulfated polysaccharides, Astragalus polysaccharides, resveratrol, and combinations thereof. These compositions find use in inducing physiological responses such, decreasing body fat, increasing lean body mass, alleviating the symptoms of colds, preventing the onset of colds, increasing energy, increasing the feeling of well-being in subjects, and improving skin tone and appearance.
Abstract:
The present invention concerns methods of isolating milk proteins. Methods of the invention include charged ultrafiltration processes that use variations in pH to further separate protein species.
Abstract:
The invention relates to prebiotics and the use thereof for promoting human health. In particular, it relates to milk-, whey- or egg-derived oligosaccharides capable of enhancing the relative abundance of beneficial micro-organisms. Provided is the use of a sialyl-oligosaccharide in the manufacture of a dietetic, nutraceutical, nutritional or pharmaceutical composition for supporting or enhancing the mammalian immune system, in particular enhancing the maturation of the developing human neonatal immune system.
Abstract:
The invention relates to prebiotics and the use thereof for promoting human health. In particular, it relates to milk-, whey- or egg-derived oligosaccharides capable of enhancing the relative abundance of beneficial micro-organisms. Provided is the use of a sialyl - oligosaccharide for the manufacture of a dietetic, nutraceutical, pharmaceutical or nutritional composition, like an infant formula, for treating or preventing a condition associated with a reduced amount of Bacteroides ssp. in the gastrointestinal tract. Also provided is an infant formula for reducing the risk of development of overweight or obesity of an infant in later life. Said composition comprises living Bacteroides ssp. in an amount of at least 10+5cfu/g dry weight of the composition.
Abstract:
The invention relates to a process for isolating sialic acid containing oligosaccharides and in particular sialyllactose from a milk stream and especially from a whey stream. The process yields a product having a high content of sialyllactose and a low content of phosphorus compounds. This product is highly suitable to be included in infant foods.
Abstract:
The present invention relates to a nutritional composition such asan infant formula comprising phospholipids in an amount of at least 300 mg/L. Bioactive compounds may preferably be added to the nutritional composition.The present invention also relates to use of said nutritional composition by feeding an infant with the nutritional composition for reducing the risk of developing metabolic syndrome, increased weight gain, increased fat deposition, overweight, obesity, insulin resistance, glucose intolerance or diabetes mellitus later in said infant's life.